The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.
Autor: | Feig, Jessica L.1, Corciulo, Carmen1, Liu, Hailing1, Perez-Aso, Miguel1, Picard, Laura1, Wilder, Tuere1, Cronstein, Bruce1, Mediero, Aranzazu1,2, Zhang, Jin1,3 |
---|---|
Zdroj: | PLoS ONE. 11/16/2017, Vol. 12 Issue 11, p1-22. 22p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |